Vcanbio Cell & Gene Engineering Corp Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vcanbio Cell & Gene Engineering Corp Ltd with three other
companies in this sector in CHINA :
Jinyu Bio-Technology Co Ltd
sales of 1.58 billion Chinese Renmimbi [US$246.10 million]
of which 96%
Beijing SL Pharmaceutical Co Ltd
(1.11 billion Chinese Renmimbi [US$173.11 million]
of which 98%
was Pharmaceuticals Industry), and
Pacific Shuanglin Bio pharmacy Co Ltd
(1.05 billion Chinese Renmimbi [US$163.34 million]
of which 99%
was Pharmaceutical Sales).
During the second
quarter of 2021, sales at Vcanbio Cell & Gene Engineering Corp Ltd totalled
396.66 million Chinese Renmimbi.
an increase of 15.9%
from the 342.35 million Chinese Renmimbi in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 767.05 million Chinese Renmimbi, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Vcanbio Cell & Gene Engineering Corp Ltd were 1.32 billion Chinese Renmimbi (US$204.88 million).
decrease of 4.9%
versus 2019, when the company's sales were 1.38 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 12.7% decline
in Services, from 548.33 million Chinese Renmimbi to 478.58 million Chinese Renmimbi.
There were also decreases in sales in
Other Operations (down 4.2% to 31.38 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Manufacturing (up 0.4% to 808.94 million Chinese Renmimbi)